NO20024489L - Multifunksjonelle polypeptider som omfatter bindingssete for en epitope av NKG2D reseptorkomplekset - Google Patents

Info

Publication number

NO20024489L

NO20024489L NO20024489A NO20024489A NO20024489L NO 20024489 L NO20024489 L NO 20024489L NO 20024489 A NO20024489 A NO 20024489A NO 20024489 A NO20024489 A NO 20024489A NO 20024489 L NO20024489 L NO 20024489L

Authority

NO

Norway

Prior art keywords

cells

cancer

multifunctional polypeptide

polypeptide according

cell

Prior art date

2000-03-24

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 title claims description 119
• 102000004196 processed proteins & peptides Human genes 0.000 title claims description 111
• 229920001184 polypeptide Polymers 0.000 title claims description 106
• 230000027455 binding Effects 0.000 title claims description 55
• 108010001657 NK Cell Lectin-Like Receptor Subfamily K Proteins 0.000 title claims description 12
• 102000000812 NK Cell Lectin-Like Receptor Subfamily K Human genes 0.000 title claims description 12
• 210000004027 cell Anatomy 0.000 claims description 239
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 90
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 86
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 79
• 239000000427 antigen Substances 0.000 claims description 72
• 108091007433 antigens Proteins 0.000 claims description 72
• 102000036639 antigens Human genes 0.000 claims description 72
• 238000000034 method Methods 0.000 claims description 61
• 239000012634 fragment Substances 0.000 claims description 52
• 239000000203 mixture Substances 0.000 claims description 50
• 239000013598 vector Substances 0.000 claims description 47
• 230000014509 gene expression Effects 0.000 claims description 46
• 206010028980 Neoplasm Diseases 0.000 claims description 43
• 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 37
• 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims description 35
• 108091033319 polynucleotide Proteins 0.000 claims description 33
• 239000002157 polynucleotide Substances 0.000 claims description 33
• 102000040430 polynucleotide Human genes 0.000 claims description 33
• 241000282414 Homo sapiens Species 0.000 claims description 29
• 239000003446 ligand Substances 0.000 claims description 28
• 102000005962 receptors Human genes 0.000 claims description 25
• 108020003175 receptors Proteins 0.000 claims description 25
• 108091008874 T cell receptors Proteins 0.000 claims description 23
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 23
• 230000001404 mediated effect Effects 0.000 claims description 23
• 241000700605 Viruses Species 0.000 claims description 21
• 201000011510 cancer Diseases 0.000 claims description 21
• 101710154606 Hemagglutinin Proteins 0.000 claims description 19
• 101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 19
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 19
• 101710176177 Protein A56 Proteins 0.000 claims description 19
• 239000000185 hemagglutinin Substances 0.000 claims description 19
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 16
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 16
• 239000012636 effector Substances 0.000 claims description 16
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 16
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 16
• 208000015181 infectious disease Diseases 0.000 claims description 16
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 16
• 201000010099 disease Diseases 0.000 claims description 14
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
• 238000002360 preparation method Methods 0.000 claims description 14
• 238000001514 detection method Methods 0.000 claims description 13
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 102100024423 Carbonic anhydrase 9 Human genes 0.000 claims description 10
• 108010009685 Cholinergic Receptors Proteins 0.000 claims description 10
• 108060003951 Immunoglobulin Proteins 0.000 claims description 10
• 102000034337 acetylcholine receptors Human genes 0.000 claims description 10
• 102000018358 immunoglobulin Human genes 0.000 claims description 10
• 239000003550 marker Substances 0.000 claims description 10
• 239000008194 pharmaceutical composition Substances 0.000 claims description 10
• 150000001413 amino acids Chemical group 0.000 claims description 9
• 206010017758 gastric cancer Diseases 0.000 claims description 9
• 239000007787 solid Substances 0.000 claims description 9
• 206010009944 Colon cancer Diseases 0.000 claims description 8
• 206010025323 Lymphomas Diseases 0.000 claims description 8
• 241000124008 Mammalia Species 0.000 claims description 8
• 101100346932 Mus musculus Muc1 gene Proteins 0.000 claims description 8
• 241000710799 Rubella virus Species 0.000 claims description 8
• 238000011282 treatment Methods 0.000 claims description 8
• 108010082808 4-1BB Ligand Proteins 0.000 claims description 7
• 102000002627 4-1BB Ligand Human genes 0.000 claims description 7
• 230000001363 autoimmune Effects 0.000 claims description 7
• 239000003937 drug carrier Substances 0.000 claims description 7
• 238000001415 gene therapy Methods 0.000 claims description 7
• 201000001441 melanoma Diseases 0.000 claims description 7
• 241000712461 unidentified influenza virus Species 0.000 claims description 7
• 241000894006 Bacteria Species 0.000 claims description 6
• 108700012439 CA9 Proteins 0.000 claims description 6
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 6
• 102000003886 Glycoproteins Human genes 0.000 claims description 6
• 108090000288 Glycoproteins Proteins 0.000 claims description 6
• 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims description 6
• 101000916489 Homo sapiens Chondroitin sulfate proteoglycan 4 Proteins 0.000 claims description 6
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 6
• 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims description 6
• 102100036735 Prostate stem cell antigen Human genes 0.000 claims description 6
• 230000008030 elimination Effects 0.000 claims description 6
• 238000003379 elimination reaction Methods 0.000 claims description 6
• 230000004048 modification Effects 0.000 claims description 6
• 238000012986 modification Methods 0.000 claims description 6
• 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 5
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 5
• 241000689227 Cora <basidiomycete fungus> Species 0.000 claims description 5
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 5
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 5
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 5
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 5
• 101000829725 Homo sapiens Phospholipid hydroperoxide glutathione peroxidase Proteins 0.000 claims description 5
• 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims description 5
• 101001056234 Homo sapiens Sperm mitochondrial-associated cysteine-rich protein Proteins 0.000 claims description 5
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 5
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims description 5
• 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 claims description 5
• 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 claims description 5
• 208000005718 Stomach Neoplasms Diseases 0.000 claims description 5
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 5
• 230000001605 fetal effect Effects 0.000 claims description 5
• 208000014829 head and neck neoplasm Diseases 0.000 claims description 5
• 230000001575 pathological effect Effects 0.000 claims description 5
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 5
• 201000011549 stomach cancer Diseases 0.000 claims description 5
• 101150047061 tag-72 gene Proteins 0.000 claims description 5
• 241001430294 unidentified retrovirus Species 0.000 claims description 5
• 208000003200 Adenoma Diseases 0.000 claims description 4
• 108091023037 Aptamer Proteins 0.000 claims description 4
• 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 4
• 102100025222 CD63 antigen Human genes 0.000 claims description 4
• 102000001301 EGF receptor Human genes 0.000 claims description 4
• 108060006698 EGF receptor Proteins 0.000 claims description 4
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
• 101100165850 Homo sapiens CA9 gene Proteins 0.000 claims description 4
• 101000934368 Homo sapiens CD63 antigen Proteins 0.000 claims description 4
• 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 claims description 4
• 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 claims description 4
• 102000036436 Metzincins Human genes 0.000 claims description 4
• 108091007161 Metzincins Proteins 0.000 claims description 4
• 206010033128 Ovarian cancer Diseases 0.000 claims description 4
• 206010060862 Prostate cancer Diseases 0.000 claims description 4
• 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 4
• 241000711798 Rabies lyssavirus Species 0.000 claims description 4
• 238000012217 deletion Methods 0.000 claims description 4
• 230000037430 deletion Effects 0.000 claims description 4
• 208000032839 leukemia Diseases 0.000 claims description 4
• 230000003211 malignant effect Effects 0.000 claims description 4
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
• 230000003612 virological effect Effects 0.000 claims description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
• 208000003174 Brain Neoplasms Diseases 0.000 claims description 3
• 102100034573 Desmoglein-4 Human genes 0.000 claims description 3
• 101710183213 Desmoglein-4 Proteins 0.000 claims description 3
• 239000004471 Glycine Substances 0.000 claims description 3
• 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 claims description 3
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 3
• 102100026712 Metalloreductase STEAP1 Human genes 0.000 claims description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 3
• 206010038389 Renal cancer Diseases 0.000 claims description 3
• 230000001580 bacterial effect Effects 0.000 claims description 3
• 230000004071 biological effect Effects 0.000 claims description 3
• 150000002500 ions Chemical class 0.000 claims description 3
• 201000005202 lung cancer Diseases 0.000 claims description 3
• 208000020816 lung neoplasm Diseases 0.000 claims description 3
• 230000002265 prevention Effects 0.000 claims description 3
• 241001529453 unidentified herpesvirus Species 0.000 claims description 3
• HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 claims description 2
• 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 2
• 208000023275 Autoimmune disease Diseases 0.000 claims description 2
• 206010003827 Autoimmune hepatitis Diseases 0.000 claims description 2
• 208000023328 Basedow disease Diseases 0.000 claims description 2
• 206010005003 Bladder cancer Diseases 0.000 claims description 2
• 102000009410 Chemokine receptor Human genes 0.000 claims description 2
• 108050000299 Chemokine receptor Proteins 0.000 claims description 2
• 108010012236 Chemokines Proteins 0.000 claims description 2
• 102000019034 Chemokines Human genes 0.000 claims description 2
• 208000035473 Communicable disease Diseases 0.000 claims description 2
• 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 2
• 206010017533 Fungal infection Diseases 0.000 claims description 2
• 241000233866 Fungi Species 0.000 claims description 2
• 208000024869 Goodpasture syndrome Diseases 0.000 claims description 2
• 208000015023 Graves' disease Diseases 0.000 claims description 2
• 208000030836 Hashimoto thyroiditis Diseases 0.000 claims description 2
• 101000991060 Homo sapiens MHC class I polypeptide-related sequence A Proteins 0.000 claims description 2
• 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 claims description 2
• 101000585344 Homo sapiens Sulfotransferase 1E1 Proteins 0.000 claims description 2
• 241000598436 Human T-cell lymphotropic virus Species 0.000 claims description 2
• 241000700588 Human alphaherpesvirus 1 Species 0.000 claims description 2
• 206010020751 Hypersensitivity Diseases 0.000 claims description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 claims description 2
• 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 claims description 2
• 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 claims description 2
• 108010000410 MSH receptor Proteins 0.000 claims description 2
• 208000031888 Mycoses Diseases 0.000 claims description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
• 208000007452 Plasmacytoma Diseases 0.000 claims description 2
• 208000015634 Rectal Neoplasms Diseases 0.000 claims description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
• 208000024313 Testicular Neoplasms Diseases 0.000 claims description 2
• 206010057644 Testis cancer Diseases 0.000 claims description 2
• 206010043515 Throat cancer Diseases 0.000 claims description 2
• 208000024770 Thyroid neoplasm Diseases 0.000 claims description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 2
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
• 208000002495 Uterine Neoplasms Diseases 0.000 claims description 2
• 108010003533 Viral Envelope Proteins Proteins 0.000 claims description 2
• 208000036142 Viral infection Diseases 0.000 claims description 2
• 208000037855 acute anterior uveitis Diseases 0.000 claims description 2
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 2
• 230000007815 allergy Effects 0.000 claims description 2
• 125000000539 amino acid group Chemical group 0.000 claims description 2
• 210000001072 colon Anatomy 0.000 claims description 2
• 208000029742 colonic neoplasm Diseases 0.000 claims description 2
• 230000004069 differentiation Effects 0.000 claims description 2
• 210000003372 endocrine gland Anatomy 0.000 claims description 2
• 201000004101 esophageal cancer Diseases 0.000 claims description 2
• 210000004392 genitalia Anatomy 0.000 claims description 2
• 201000005787 hematologic cancer Diseases 0.000 claims description 2
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims description 2
• 210000002865 immune cell Anatomy 0.000 claims description 2
• 239000012678 infectious agent Substances 0.000 claims description 2
• 230000000968 intestinal effect Effects 0.000 claims description 2
• 210000003228 intrahepatic bile duct Anatomy 0.000 claims description 2
• 208000014899 intrahepatic bile duct cancer Diseases 0.000 claims description 2
• 201000010982 kidney cancer Diseases 0.000 claims description 2
• 208000014018 liver neoplasm Diseases 0.000 claims description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
• 210000002752 melanocyte Anatomy 0.000 claims description 2
• 210000004779 membrane envelope Anatomy 0.000 claims description 2
• 201000006417 multiple sclerosis Diseases 0.000 claims description 2
• 206010028417 myasthenia gravis Diseases 0.000 claims description 2
• 201000002528 pancreatic cancer Diseases 0.000 claims description 2
• 206010038038 rectal cancer Diseases 0.000 claims description 2
• 201000001275 rectum cancer Diseases 0.000 claims description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
• 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 2
• 201000003120 testicular cancer Diseases 0.000 claims description 2
• 201000002510 thyroid cancer Diseases 0.000 claims description 2
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 claims description 2
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
• 206010046766 uterine cancer Diseases 0.000 claims description 2
• 101100182712 Mus musculus Ly6a gene Proteins 0.000 claims 2
• 102100026503 Sperm mitochondrial-associated cysteine-rich protein Human genes 0.000 claims 2
• 208000035143 Bacterial infection Diseases 0.000 claims 1
• 241001500351 Influenzavirus A Species 0.000 claims 1
• 241001500350 Influenzavirus B Species 0.000 claims 1
• 241001500343 Influenzavirus C Species 0.000 claims 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
• 208000022362 bacterial infectious disease Diseases 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 208000026037 malignant tumor of neck Diseases 0.000 claims 1
• 230000007935 neutral effect Effects 0.000 claims 1
• 210000000496 pancreas Anatomy 0.000 claims 1
• 238000002203 pretreatment Methods 0.000 claims 1
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 62
• 108090000623 proteins and genes Proteins 0.000 description 48
• 210000000822 natural killer cell Anatomy 0.000 description 43
• 239000006228 supernatant Substances 0.000 description 37
• 102000004169 proteins and genes Human genes 0.000 description 34
• 210000004408 hybridoma Anatomy 0.000 description 29
• 235000018102 proteins Nutrition 0.000 description 28
• 230000006870 function Effects 0.000 description 22
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 21
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 20
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 20
• 238000010790 dilution Methods 0.000 description 19
• 239000012895 dilution Substances 0.000 description 19
• 238000002965 ELISA Methods 0.000 description 18
• 210000004698 lymphocyte Anatomy 0.000 description 18
• 239000013612 plasmid Substances 0.000 description 18
• 108020004414 DNA Proteins 0.000 description 17
• 230000001472 cytotoxic effect Effects 0.000 description 17
• 239000000243 solution Substances 0.000 description 17
• 241000699670 Mus sp. Species 0.000 description 16
• 241000699666 Mus <mouse, genus> Species 0.000 description 15
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 15
• 231100000433 cytotoxic Toxicity 0.000 description 14
• 210000002966 serum Anatomy 0.000 description 14
• 238000000746 purification Methods 0.000 description 13
• 108010004729 Phycoerythrin Proteins 0.000 description 12
• 238000000684 flow cytometry Methods 0.000 description 12
• 238000003752 polymerase chain reaction Methods 0.000 description 12
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 11
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 11
• 210000004899 c-terminal region Anatomy 0.000 description 11
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 11
• 239000012228 culture supernatant Substances 0.000 description 11
• 230000009089 cytolysis Effects 0.000 description 11
• 239000013604 expression vector Substances 0.000 description 11
• 239000002953 phosphate buffered saline Substances 0.000 description 11
• 239000000047 product Substances 0.000 description 11
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 10
• 230000004927 fusion Effects 0.000 description 10
• 230000003053 immunization Effects 0.000 description 10
• 238000011534 incubation Methods 0.000 description 10
• 150000007523 nucleic acids Chemical class 0.000 description 10
• 238000010186 staining Methods 0.000 description 10
• 238000001890 transfection Methods 0.000 description 10
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 9
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 9
• 150000001875 compounds Chemical class 0.000 description 9
• 238000002474 experimental method Methods 0.000 description 9
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 9
• 238000002649 immunization Methods 0.000 description 9
• 238000000338 in vitro Methods 0.000 description 9
• 108020004707 nucleic acids Proteins 0.000 description 9
• 102000039446 nucleic acids Human genes 0.000 description 9
• 102000006306 Antigen Receptors Human genes 0.000 description 8
• 108010083359 Antigen Receptors Proteins 0.000 description 8
• 241000588724 Escherichia coli Species 0.000 description 8
• 241001529936 Murinae Species 0.000 description 8
• 206010037742 Rabies Diseases 0.000 description 8
• 229940024606 amino acid Drugs 0.000 description 8
• 235000001014 amino acid Nutrition 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• 230000003013 cytotoxicity Effects 0.000 description 8
• 231100000135 cytotoxicity Toxicity 0.000 description 8
• 238000009472 formulation Methods 0.000 description 8
• 238000004091 panning Methods 0.000 description 8
• 239000013615 primer Substances 0.000 description 8
• 230000037452 priming Effects 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
• 108091026890 Coding region Proteins 0.000 description 7
• 108010010995 MART-1 Antigen Proteins 0.000 description 7
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 7
• 210000004369 blood Anatomy 0.000 description 7
• 239000008280 blood Substances 0.000 description 7
• 238000004113 cell culture Methods 0.000 description 7
• 230000000694 effects Effects 0.000 description 7
• 108020001507 fusion proteins Proteins 0.000 description 7
• 102000037865 fusion proteins Human genes 0.000 description 7
• 102000044042 human KLRK1 Human genes 0.000 description 7
• 239000007788 liquid Substances 0.000 description 7
• 108091008146 restriction endonucleases Proteins 0.000 description 7
• 230000019491 signal transduction Effects 0.000 description 7
• 230000014616 translation Effects 0.000 description 7
• 102100031940 Epithelial cell adhesion molecule Human genes 0.000 description 6
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 6
• 206010041067 Small cell lung cancer Diseases 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• 239000002671 adjuvant Substances 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• 239000000969 carrier Substances 0.000 description 6
• 230000006037 cell lysis Effects 0.000 description 6
• 238000010367 cloning Methods 0.000 description 6
• 238000010276 construction Methods 0.000 description 6
• 230000000139 costimulatory effect Effects 0.000 description 6
• 230000001086 cytosolic effect Effects 0.000 description 6
• -1 desmogelin 4 Proteins 0.000 description 6
• 229940079593 drug Drugs 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 6
• 230000001965 increasing effect Effects 0.000 description 6
• 206010022000 influenza Diseases 0.000 description 6
• 239000013642 negative control Substances 0.000 description 6
• 125000003729 nucleotide group Chemical group 0.000 description 6
• 230000007115 recruitment Effects 0.000 description 6
• 208000000587 small cell lung carcinoma Diseases 0.000 description 6
• 230000002269 spontaneous effect Effects 0.000 description 6
• 241000701447 unidentified baculovirus Species 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• 206010006187 Breast cancer Diseases 0.000 description 5
• 208000026310 Breast neoplasm Diseases 0.000 description 5
• 241000238631 Hexapoda Species 0.000 description 5
• 208000017604 Hodgkin disease Diseases 0.000 description 5
• 108010029485 Protein Isoforms Proteins 0.000 description 5
• 102000001708 Protein Isoforms Human genes 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 239000004480 active ingredient Substances 0.000 description 5
• 125000003275 alpha amino acid group Chemical group 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 239000002299 complementary DNA Substances 0.000 description 5
• 239000006071 cream Substances 0.000 description 5
• 238000004925 denaturation Methods 0.000 description 5
• 230000036425 denaturation Effects 0.000 description 5
• 239000003085 diluting agent Substances 0.000 description 5
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 239000002773 nucleotide Substances 0.000 description 5
• 239000003921 oil Substances 0.000 description 5
• 235000019198 oils Nutrition 0.000 description 5
• 230000001105 regulatory effect Effects 0.000 description 5
• 230000010076 replication Effects 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 230000001225 therapeutic effect Effects 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• 208000004736 B-Cell Leukemia Diseases 0.000 description 4
• 102100028757 Chondroitin sulfate proteoglycan 4 Human genes 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 102000003992 Peroxidases Human genes 0.000 description 4
• 206010035226 Plasma cell myeloma Diseases 0.000 description 4
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
• 238000004458 analytical method Methods 0.000 description 4
• 230000001588 bifunctional effect Effects 0.000 description 4
• 239000000839 emulsion Substances 0.000 description 4
• 238000012921 fluorescence analysis Methods 0.000 description 4
• 208000010749 gastric carcinoma Diseases 0.000 description 4
• 230000028993 immune response Effects 0.000 description 4
• 208000037797 influenza A Diseases 0.000 description 4
• 239000004615 ingredient Substances 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 239000007937 lozenge Substances 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 210000005259 peripheral blood Anatomy 0.000 description 4
• 239000011886 peripheral blood Substances 0.000 description 4
• 108040007629 peroxidase activity proteins Proteins 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 239000002244 precipitate Substances 0.000 description 4
• 210000003491 skin Anatomy 0.000 description 4
• 210000004989 spleen cell Anatomy 0.000 description 4
• 201000000498 stomach carcinoma Diseases 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• 238000011144 upstream manufacturing Methods 0.000 description 4
• 239000011534 wash buffer Substances 0.000 description 4
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• 208000003950 B-cell lymphoma Diseases 0.000 description 3
• 238000011725 BALB/c mouse Methods 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• 102000000905 Cadherin Human genes 0.000 description 3
• 108050007957 Cadherin Proteins 0.000 description 3
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
• 101150074155 DHFR gene Proteins 0.000 description 3
• 108010013369 Enteropeptidase Proteins 0.000 description 3
• 102100029727 Enteropeptidase Human genes 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 229920001917 Ficoll Polymers 0.000 description 3
• 101710133291 Hemagglutinin-neuraminidase Proteins 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 description 3
• 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 3
• 208000034578 Multiple myelomas Diseases 0.000 description 3
• 102000005348 Neuraminidase Human genes 0.000 description 3
• 108010006232 Neuraminidase Proteins 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 241000276498 Pollachius virens Species 0.000 description 3
• 108010076504 Protein Sorting Signals Proteins 0.000 description 3
• 239000012980 RPMI-1640 medium Substances 0.000 description 3
• 230000006044 T cell activation Effects 0.000 description 3
• 230000037453 T cell priming Effects 0.000 description 3
• 102100027208 T-cell antigen CD7 Human genes 0.000 description 3
• 108091023040 Transcription factor Proteins 0.000 description 3
• 102000040945 Transcription factor Human genes 0.000 description 3
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
• 238000001042 affinity chromatography Methods 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 230000000844 anti-bacterial effect Effects 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 239000003899 bactericide agent Substances 0.000 description 3
• 230000008827 biological function Effects 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 238000003271 compound fluorescence assay Methods 0.000 description 3
• 239000000562 conjugate Substances 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 239000001963 growth medium Substances 0.000 description 3
• 201000010536 head and neck cancer Diseases 0.000 description 3
• 208000037798 influenza B Diseases 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 238000002156 mixing Methods 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 239000002674 ointment Substances 0.000 description 3
• 239000013600 plasmid vector Substances 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 238000012216 screening Methods 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 238000004114 suspension culture Methods 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 230000010474 transient expression Effects 0.000 description 3
• 230000001960 triggered effect Effects 0.000 description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
• YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 201000009030 Carcinoma Diseases 0.000 description 2
• VYZAMTAEIAYCRO-BJUDXGSMSA-N Chromium-51 Chemical compound [51Cr] VYZAMTAEIAYCRO-BJUDXGSMSA-N 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 208000003606 Congenital Rubella Syndrome Diseases 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 241000701022 Cytomegalovirus Species 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
• 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 2
• 101000759926 Homo sapiens Ubiquitin carboxyl-terminal hydrolase isozyme L1 Proteins 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• 108010073807 IgG Receptors Proteins 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
• 239000004166 Lanolin Substances 0.000 description 2
• 108090001090 Lectins Proteins 0.000 description 2
• 102000004856 Lectins Human genes 0.000 description 2
• 108091008877 NK cell receptors Proteins 0.000 description 2
• 102000010648 Natural Killer Cell Receptors Human genes 0.000 description 2
• 108091028043 Nucleic acid sequence Proteins 0.000 description 2
• 102000052812 Ornithine decarboxylases Human genes 0.000 description 2
• 108700005126 Ornithine decarboxylases Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 235000019483 Peanut oil Nutrition 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 208000007660 Residual Neoplasm Diseases 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 108091081024 Start codon Proteins 0.000 description 2
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
• 102100025038 Ubiquitin carboxyl-terminal hydrolase isozyme L1 Human genes 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 240000008042 Zea mays Species 0.000 description 2
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 239000011543 agarose gel Substances 0.000 description 2
• 229960000723 ampicillin Drugs 0.000 description 2
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
• 230000006907 apoptotic process Effects 0.000 description 2
• 108010005774 beta-Galactosidase Proteins 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 239000008366 buffered solution Substances 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 210000004671 cell-free system Anatomy 0.000 description 2
• 208000019065 cervical carcinoma Diseases 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• 235000005822 corn Nutrition 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 238000012137 double-staining Methods 0.000 description 2
• VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 230000007717 exclusion Effects 0.000 description 2
• 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 239000012894 fetal calf serum Substances 0.000 description 2
• 238000001914 filtration Methods 0.000 description 2
• 230000003325 follicular Effects 0.000 description 2
• 239000000417 fungicide Substances 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 238000001476 gene delivery Methods 0.000 description 2
• 239000000833 heterodimer Substances 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 229940116886 human interleukin-6 Drugs 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 208000037799 influenza C Diseases 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 235000019388 lanolin Nutrition 0.000 description 2
• 229940039717 lanolin Drugs 0.000 description 2
• 239000002523 lectin Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
• 201000000050 myeloid neoplasm Diseases 0.000 description 2
• 230000003472 neutralizing effect Effects 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
• 239000004006 olive oil Substances 0.000 description 2
• 235000008390 olive oil Nutrition 0.000 description 2
• 239000006072 paste Substances 0.000 description 2
• 239000000312 peanut oil Substances 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• 210000001322 periplasm Anatomy 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 230000008488 polyadenylation Effects 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 239000000651 prodrug Substances 0.000 description 2
• 229940002612 prodrug Drugs 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 2
• 201000005404 rubella Diseases 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 235000020183 skimmed milk Nutrition 0.000 description 2
• 229910000029 sodium carbonate Inorganic materials 0.000 description 2
• 235000017550 sodium carbonate Nutrition 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 230000009870 specific binding Effects 0.000 description 2
• 239000008174 sterile solution Substances 0.000 description 2
• 239000008223 sterile water Substances 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 238000007910 systemic administration Methods 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000014621 translational initiation Effects 0.000 description 2
• 230000017105 transposition Effects 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 230000006433 tumor necrosis factor production Effects 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• LINMATFDVHBYOS-MBJXGIAVSA-N (2s,3r,4s,5r,6r)-2-[(5-bromo-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C=C12 LINMATFDVHBYOS-MBJXGIAVSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• 108020005345 3' Untranslated Regions Proteins 0.000 description 1
• CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
• 108020003589 5' Untranslated Regions Proteins 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 101150094949 APRT gene Proteins 0.000 description 1
• 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 1
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 244000144725 Amygdalus communis Species 0.000 description 1
• 235000011437 Amygdalus communis Nutrition 0.000 description 1
• 206010002515 Animal bite Diseases 0.000 description 1
• 108010032595 Antibody Binding Sites Proteins 0.000 description 1
• 235000017060 Arachis glabrata Nutrition 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 235000010777 Arachis hypogaea Nutrition 0.000 description 1
• 235000018262 Arachis monticola Nutrition 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
• 102000002086 C-type lectin-like Human genes 0.000 description 1
• 108050009406 C-type lectin-like Proteins 0.000 description 1
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• 102100025473 Carcinoembryonic antigen-related cell adhesion molecule 6 Human genes 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 206010057248 Cell death Diseases 0.000 description 1
• 241000288673 Chiroptera Species 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 208000032170 Congenital Abnormalities Diseases 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 101100015729 Drosophila melanogaster drk gene Proteins 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 238000008157 ELISA kit Methods 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• 241000724791 Filamentous phage Species 0.000 description 1
• 206010016852 Foetal damage Diseases 0.000 description 1
• 206010017964 Gastrointestinal infection Diseases 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 206010018498 Goitre Diseases 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 239000012981 Hank's balanced salt solution Substances 0.000 description 1
• 244000043261 Hevea brasiliensis Species 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
• 101000914326 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 6 Proteins 0.000 description 1
• 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 description 1
• 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 description 1
• 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 description 1
• 101000607306 Homo sapiens UL16-binding protein 1 Proteins 0.000 description 1
• 101000607320 Homo sapiens UL16-binding protein 2 Proteins 0.000 description 1
• 101000599037 Homo sapiens Zinc finger protein Helios Proteins 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 241000712431 Influenza A virus Species 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 102100024032 Linker for activation of T-cells family member 1 Human genes 0.000 description 1
• 239000006142 Luria-Bertani Agar Substances 0.000 description 1
• 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• PKVZBNCYEICAQP-UHFFFAOYSA-N Mecamylamine hydrochloride Chemical compound Cl.C1CC2C(C)(C)C(NC)(C)C1C2 PKVZBNCYEICAQP-UHFFFAOYSA-N 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• 229920000715 Mucilage Polymers 0.000 description 1
• 108010008707 Mucin-1 Proteins 0.000 description 1
• 102100034256 Mucin-1 Human genes 0.000 description 1
• 108010063954 Mucins Proteins 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 230000004988 N-glycosylation Effects 0.000 description 1
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• 206010028851 Necrosis Diseases 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
• 208000037273 Pathologic Processes Diseases 0.000 description 1
• 201000011152 Pemphigus Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
• 206010035148 Plague Diseases 0.000 description 1
• 229920003171 Poly (ethylene oxide) Chemical class 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 101710120463 Prostate stem cell antigen Proteins 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 241000256248 Spodoptera Species 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 230000006043 T cell recruitment Effects 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 102000002933 Thioredoxin Human genes 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 102100040012 UL16-binding protein 1 Human genes 0.000 description 1
• 102100039989 UL16-binding protein 2 Human genes 0.000 description 1
• 230000006750 UV protection Effects 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 description 1
• 241000607479 Yersinia pestis Species 0.000 description 1
• 108010046882 ZAP-70 Protein-Tyrosine Kinase Proteins 0.000 description 1
• 102000007624 ZAP-70 Protein-Tyrosine Kinase Human genes 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000008186 active pharmaceutical agent Substances 0.000 description 1
• 108091005764 adaptor proteins Proteins 0.000 description 1
• 102000035181 adaptor proteins Human genes 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 238000009098 adjuvant therapy Methods 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 235000020224 almond Nutrition 0.000 description 1
• SRHNADOZAAWYLV-XLMUYGLTSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O SRHNADOZAAWYLV-XLMUYGLTSA-N 0.000 description 1
• DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 239000003708 ampul Substances 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 239000003945 anionic surfactant Substances 0.000 description 1
• 150000001450 anions Chemical class 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 101150042295 arfA gene Proteins 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• CXQCLLQQYTUUKJ-ALWAHNIESA-N beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer(d18:1/18:0) Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@@H](CO)O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 CXQCLLQQYTUUKJ-ALWAHNIESA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 108010006025 bovine growth hormone Proteins 0.000 description 1
• 201000008275 breast carcinoma Diseases 0.000 description 1
• 210000004900 c-terminal fragment Anatomy 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 239000007894 caplet Substances 0.000 description 1
• 229960003669 carbenicillin Drugs 0.000 description 1
• FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 235000019438 castor oil Nutrition 0.000 description 1
• 238000005277 cation exchange chromatography Methods 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 239000003093 cationic surfactant Substances 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000005889 cellular cytotoxicity Effects 0.000 description 1
• 230000007541 cellular toxicity Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 229960002152 chlorhexidine acetate Drugs 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 239000013599 cloning vector Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 108091008034 costimulatory receptors Proteins 0.000 description 1
• 230000037029 cross reaction Effects 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 230000001461 cytolytic effect Effects 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000000432 density-gradient centrifugation Methods 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 208000019836 digestive system infectious disease Diseases 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 108020001096 dihydrofolate reductase Proteins 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 229910000397 disodium phosphate Inorganic materials 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 230000007783 downstream signaling Effects 0.000 description 1
• 239000006196 drop Substances 0.000 description 1
• 238000001647 drug administration Methods 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 210000002308 embryonic cell Anatomy 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 201000003444 follicular lymphoma Diseases 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
• 229940074045 glyceryl distearate Drugs 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 201000003872 goiter Diseases 0.000 description 1
• 101150098203 grb2 gene Proteins 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
• 101150113423 hisD gene Proteins 0.000 description 1
• 108091008039 hormone receptors Proteins 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 150000002430 hydrocarbons Chemical class 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
• 101150026046 iga gene Proteins 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 239000012642 immune effector Substances 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 230000010189 intracellular transport Effects 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 231100000636 lethal dose Toxicity 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 239000000865 liniment Substances 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 229940057995 liquid paraffin Drugs 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 210000000207 lymphocyte subset Anatomy 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000034217 membrane fusion Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 150000004702 methyl esters Chemical class 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 229960000951 mycophenolic acid Drugs 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• QCQYVCMYGCHVMR-AAZUGDAUSA-N n-[(2r,3r,4s,5r)-4,5,6-trihydroxy-1-oxo-3-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide Chemical compound CC(=O)N[C@@H](C=O)[C@H]([C@@H](O)[C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O QCQYVCMYGCHVMR-AAZUGDAUSA-N 0.000 description 1
• 229920003052 natural elastomer Polymers 0.000 description 1
• 229920001194 natural rubber Polymers 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 230000021616 negative regulation of cell division Effects 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 239000002736 nonionic surfactant Substances 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 101150087557 omcB gene Proteins 0.000 description 1
• 101150115693 ompA gene Proteins 0.000 description 1
• 230000005305 organ development Effects 0.000 description 1
• 239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 230000001769 paralizing effect Effects 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000009054 pathological process Effects 0.000 description 1
• 235000020232 peanut Nutrition 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 201000001976 pemphigus vulgaris Diseases 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 239000000863 peptide conjugate Substances 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 1
• 101150009573 phoA gene Proteins 0.000 description 1
• 229940080469 phosphocellulose Drugs 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 210000004180 plasmocyte Anatomy 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 230000035935 pregnancy Effects 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 210000004986 primary T-cell Anatomy 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 201000001514 prostate carcinoma Diseases 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000005180 public health Effects 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• 108010045647 puromycin N-acetyltransferase Proteins 0.000 description 1
• 229960003127 rabies vaccine Drugs 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 201000010174 renal carcinoma Diseases 0.000 description 1
• 230000000754 repressing effect Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 230000003584 silencer Effects 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 239000000344 soap Substances 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 229940043517 specific immunoglobulins Drugs 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 108010087686 src-Family Kinases Proteins 0.000 description 1
• 102000009076 src-Family Kinases Human genes 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• FRGKKTITADJNOE-UHFFFAOYSA-N sulfanyloxyethane Chemical compound CCOS FRGKKTITADJNOE-UHFFFAOYSA-N 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 238000011287 therapeutic dose Methods 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 108060008226 thioredoxin Proteins 0.000 description 1
• 229940094937 thioredoxin Drugs 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 238000011200 topical administration Methods 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 239000012096 transfection reagent Substances 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• 108091007466 transmembrane glycoproteins Proteins 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 101150081616 trpB gene Proteins 0.000 description 1
• 101150111232 trpB-1 gene Proteins 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 230000009750 upstream signaling Effects 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1